by Marina Chenery | Nov 23, 2022 | News
New role will lead technology development as the Company continues to scale team and global business operations. The appointment of former Merck, Sharp and Dohme (MSD) Director of R&D Analytics supports continued innovation of Optibrium’s AI drug discovery...
by Marina Chenery | Nov 9, 2022 | Webinars
The Power of AI Applied to Agrochemical Bioactivity In the face of growing agrochemical resistance and increasingly stringent regulatory requirements, how can artificial intelligence (AI) be harnessed to help lower the costs, failure rates and timelines associated...
by Michelle Harrison | Nov 2, 2022 | News
Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes Optibrium and Lhasa Limited publish joint peer-reviewed research in the Journal of Medicinal Chemistry, expanding predictive modelling beyond human Cytochrome P450. Study...